Health Care & Life Sciences » Biotechnology | OncoMed Pharmaceuticals Inc.

OncoMed Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
37,779.00
39,559.00
25,899.00
25,153.00
38,154.00
SG&A Expense
60,300.00
88,753.00
109,813.00
126,776.00
74,890.00
EBIT
23,899.00
50,624.00
85,557.00
103,387.00
38,446.00
Unusual Expense
280.00
-
-
-
2,527.00
Non Operating Income/Expense
508.00
-
-
-
-
Pretax Income
24,127.00
50,519.00
85,387.00
103,088.00
40,145.00
Income Tax
1,944.00
509.00
20.00
14.00
1,083.00
Consolidated Net Income
26,071.00
50,010.00
85,407.00
103,102.00
39,062.00
Net Income
26,071.00
50,010.00
85,407.00
103,102.00
39,062.00
Net Income After Extraordinaries
26,071.00
50,010.00
85,407.00
103,102.00
39,062.00
Net Income Available to Common
26,071.00
50,010.00
85,407.00
103,102.00
39,062.00
EPS (Basic)
1.93
1.69
2.84
3.14
1.04
Basic Shares Outstanding
13,530.20
29,664.30
30,028.70
32,859.60
37,631.30
EPS (Diluted)
1.93
1.69
2.84
3.14
1.04
Diluted Shares Outstanding
13,530.20
29,664.30
30,028.70
32,859.60
37,631.30
EBITDA
22,521.00
49,194.00
83,914.00
101,623.00
36,736.00
Non-Operating Interest Income
-
105.00
170.00
299.00
828.00

About OncoMed Pharmaceuticals

View Profile
Address
800 Chesapeake Drive
Redwood City California 94063
United States
Employees -
Website http://www.oncomed.com
Updated 09/14/2018
OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.